Market Update: COR, ADM, NI
Source link
Market Update: COR, ADM, NI
Spyre Therapeutics Plunges; Why Analysts Aren’t Sweating
Spyre Therapeutics (SYRE) took a hit Wednesday after its experimental rheumatoid arthritis treatment failed to pass muster in midstage testing. But analysts are far more […]